Donnerstag, 17.06.19 23:25
Bildquelle: iStock by Getty Images


Quelle: boerse.de

News und Analysen

Navidea Biopharmaceuticals Announces Day and Time of SNMMI Presentation of Phase 1/2 Study Results and Enrollment Update on its Phase 2B Study

DUBLIN, Ohio – Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic ...weiterlesen

Seite: 1 | 2 | 3 | 4 | 5 | 6 | ... | 11428